Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
T

BCL-2 Family Inhibitors in CLL

By Indy Hematology Review FEATURING Thomas Kipps
By Indy Hematology Review FEATURING Thomas Kipps
330 views
May 16, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Leukemia
03:02
Indy Hematology Review

Diagnostic criteria for Chronic Neurophilic Leukemia

Feat. A. Tefferi
06:53
Indy Hematology Review

Chronic Myelomonocytic Leukemia: Define, Diagnosis, Prognostications…

Feat. A. Tefferi
18:15
Indy Hematology Review

State-of-the-Art 2018 Acute Myeloid Leukemia

Feat. M. Tallman
11:08
Indy Hematology Review

Relapse Refractory Acute Myeloid Leukemia

Feat. M. Tallman
11:06
Indy Hematology Review

Personalized Therapy in Adult Lymphocytic Leukemia: Path to the Cure

Feat. E. Jabbour
09:14
Indy Hematology Review

Relapse and Refractory Acute Lymphoblastic Leukemia

Feat. E. Jabbour
12:09
Indy Hematology Review

Intro to CLL - Genetic lesions and prognostic markers

Feat. T. Kipps
08:43
Indy Hematology Review

B-cell Receptor Signaling in CLL

Feat. T. Kipps
05:56
Indy Hematology Review

BCL-2 Family Inhibitors in CLL

Feat. T. Kipps
21:19
Indy Hematology Review

Current Treatment Algorithm For Patients with CLL

Feat. T. Kipps
07:28
Indy Hematology Review

CAR T-cell Therapy in CLL

Feat. T. Kipps
03:47
Indy Hematology Review

Challenging Cases in Leukemia: AML & ALL

Feat. M. Wiemann